Update on Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on QT Interval, Left Ventricular Dysfunction and Overall Risk/Benefit
Crossref DOI link: https://doi.org/10.1007/s40264-015-0300-1
Published Online: 2015-05-26
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shah, Rashmi R.
Morganroth, Joel
Text and Data Mining valid from 2015-05-26